Synedica Retatrutide 40mg Pen Price UK: Research Product Guide
Searching for the Synedica Retatrutide 40mg pen price in the UK? This guide covers the current catalogue listing, the 40mg product format, pricing information, bulk alternatives and the UK research-use context surrounding retatrutide.
The current catalogue lists a Retatrutide Triple Agonist Injection Pen Kit — 40mg Total at £110.
This page is intended to help researchers and buyers understand the catalogue information before reviewing the relevant product listing.
Retatrutide 40mg Pen Price UK
The current listed price for the 40mg Retatrutide Triple Agonist Injection Pen Kit is:
£110
The catalogue identifies the product as containing 40mg total.
For anyone comparing UK research-product prices, this provides a straightforward reference point for the current individual 40mg pen listing.
Prices can change, so always verify the live catalogue listing before placing an order.
Retatrutide 40mg Pen for Sale in the UK
Searches for Retatrutide 40mg pen for sale UK generally indicate strong commercial intent. People using this search may be looking for:
- Current 40mg pricing
- Product availability
- Research-product specifications
- UK catalogue information
- Bulk purchasing options
- Product documentation
- Research-use conditions
It is important to distinguish a research-product catalogue listing from an authorised pharmaceutical medicine.
The current UK regulatory record shows retatrutide remains in clinical development rather than being an established general-use medicine. The MHRA currently records retatrutide under a paediatric investigation plan for obesity, with Eli Lilly and Company Ltd identified as the applicant.
Current 40mg Pricing
For quick reference:
| Research product | Stated amount | Current listed price |
|---|---|---|
| Retatrutide Triple Agonist Injection Pen Kit | 40mg total | £110 |
| Retatrutide 40mg Bulk Price | 40mg / quantity-based options | £130–£6,200 |
The pen and bulk products are separate catalogue listings, so they should be compared based on their individual specifications rather than treating them as identical products.
What Is a Retatrutide 40mg Pen?
Retatrutide is an investigational compound being studied in pharmaceutical research.
It is commonly described as a triple receptor agonist, with research focused on activity involving the GLP-1, GIP and glucagon receptor pathways.
A 40mg pen listing therefore refers to a particular research-product format and stated quantity.
The 40mg designation should not be interpreted as a recommended human dose.
This page does not provide dosing or administration instructions.
Why Researchers Search for 40mg Pricing
The phrase Retatrutide 40mg pen price UK combines several commercial and informational signals.
A researcher comparing products may want to know:
Product amount:
How much material is represented by the listing?
Format:
Is the material supplied as a pen or another format?
Price:
What is the current catalogue cost?
Documentation:
What product information or laboratory documentation is available?
Quantity options:
Are individual and bulk purchasing options listed separately?
These factors are more useful for research purchasing decisions than looking at headline price alone.
40mg Pen vs Bulk Retatrutide
The current catalogue provides both an individual 40mg pen listing and a separate bulk-price listing.
40mg Pen
Listed price: £110
This is the current catalogue price displayed for the 40mg Retatrutide Triple Agonist Injection Pen Kit.
Bulk Listing
The separate Retatrutide 40mg Bulk Price listing currently displays a range of £130–£6,200.
The difference between the displayed prices reflects the fact that the bulk listing covers different purchasing quantities.
For serious purchasing comparisons, calculate the effective cost per unit rather than comparing only the highest or lowest displayed price.
What to Check Before Buying Research Material
If you are evaluating a research product in the UK, consider the following information before purchasing.
1. Product identity
Check the exact product name and stated quantity.
2. Product format
Confirm whether you are reviewing the 40mg pen listing or a separate bulk product.
3. Current catalogue price
Prices may change, so use the current product page rather than relying on an old screenshot or search result.
4. Documentation
Review available product information and laboratory documentation where provided.
5. Research-use status
Confirm that the material is supplied for its stated research purpose and understand the applicable restrictions.
6. UK regulatory status
Do not confuse a commercial research listing with MHRA authorisation as a medicine.
Is Retatrutide Approved in the UK?
Retatrutide remains an investigational product.
The MHRA’s current database contains a July 2026 paediatric investigation-plan record for retatrutide, with obesity listed as the condition and solution for injection as the pharmaceutical form.
This is evidence of ongoing regulatory and clinical-development activity, not evidence that retatrutide has been authorised for general sale as a medicine in the UK.
Consequently, research-product information should not be presented as pharmaceutical approval or a recommendation for personal treatment.
Retatrutide 40mg UK Price: What £110 Means
The £110 figure refers specifically to the current catalogue price displayed for the 40mg Retatrutide Triple Agonist Injection Pen Kit.
It should not be described as:
- A prescription medicine price
- A healthcare treatment price
- A recommended patient price
- A medically approved treatment cost
It is a catalogue price associated with a research product.
Frequently Asked Questions
How much is the Retatrutide 40mg pen in the UK?
The current catalogue lists the 40mg Retatrutide Triple Agonist Injection Pen Kit at £110.
Is there a Retatrutide 40mg pen for sale in the UK?
A 40mg research-product pen is currently listed in the catalogue at £110. The listing should be understood within its stated research-use context.
What is the Retatrutide 40mg price in the UK?
The current listed price for the 40mg pen is £110. A separate bulk listing displays £130–£6,200, depending on quantity.
Is the 40mg pen the same as the bulk product?
No. They are presented as separate catalogue products. The pen listing specifies 40mg total, while the bulk listing provides quantity-based pricing.
Is retatrutide a UK-approved medicine?
The current MHRA record shows retatrutide remains in clinical development. The presence of an MHRA paediatric investigation plan does not mean that the product has been authorised for general medical use.
Can the 40mg research product be used as a medicine?
Research products should not be presented as approved medicines or substitutes for regulated medical treatment. This page does not provide instructions for human or veterinary use.
UK Retatrutide Price Comparison
For buyers researching the current catalogue, the key figures are:
40mg Retatrutide pen: £110
Retatrutide 40mg bulk listing: £130–£6,200
When comparing these options, consider the product format, quantity, documentation and research-use conditions alongside price.
Final Summary
For the search Synedica Retatrutide 40mg Pen Price UK, the current catalogue reference is £110 for the 40mg Retatrutide Triple Agonist Injection Pen Kit.
A separate bulk listing currently displays £130–£6,200, providing a second pricing route for buyers comparing different quantities.
Because retatrutide remains under clinical development, pricing and catalogue availability should be separated from pharmaceutical approval. The MHRA’s current records confirm ongoing development activity involving retatrutide in the UK.
Research-use notice: Product information on this page is provided for research and informational purposes. Retatrutide is not presented as an approved medicine, and this article does not provide medical advice, dosing instructions or recommendations for human or veterinary use.
